Suppr超能文献

前列腺素E2输注对人体的代谢影响:可能的肾上腺素能介导作用。

Metabolic effects of prostaglandin E2 infusion in man: possible adrenergic mediation.

作者信息

Newman W P, Brodows R G

出版信息

J Clin Endocrinol Metab. 1982 Sep;55(3):496-501. doi: 10.1210/jcem-55-3-496.

Abstract

Infusion of prostaglandin E2 (PGE2) has been previously shown to inhibit acute insulin release and cause glucose intolerance. The present studies were undertaken to assess the effects of PGE2 on 1) pancreatic beta-cell sensitivity to glucose, 2) glucose tolerance, 3) tissue sensitivity to insulin, 4) glucose production and clearance, and 5) plasma catecholamine, glucagon, and FFA levels. Six healthy adult subjects were studied with the hyperglycemic clamp technique (plasma glucose 125 mg/dl above basal for 2 h) before and 30 min after the start of a PGE2 infusion (10 micrograms/min). Plasma epinephrine, norepinephrine, and FFA were measured during the PGE2 infusion. In additional experiments, glucose production and utilization were measured isotopically ([3-3H]glucose) during PGE2 infusion. PG infusion diminished, but not significantly, acute insulin release (0-10 min preinfusion, 172 +/- 36; postinfusion, 148 +/- 45 microunits/ml . 10 min). Late insulin release (20-120 min) was unchanged. A significant decline occurred in the amount of glucose metabolized from 9 +/- 1.1 to 7.2 +/- 1 mg/kg . min. During the initial 30 min of PGE2 infusion, plasma FFA increased by 26 +/- 6% (P less than 0.025). Plasma epinephrine and norepinephrine rose from 40 +/- 6 to 104 +/- 24 pg/ml (P less than 0.05) and 204 +/- 17 to 440 +/- 30 pg/ml (P less than 0.01), respectively. PGE2 produced a prompt 30% rise in glucose output, which declined to basal levels by 60 min. Glucose clearance decreased transiently at 45 min by 23%. We conclude that the effects on glucose homeostasis noted during PGE2 infusion occur in the face of heightened adrenergic activity. These metabolic responses closely resemble adrenergically induced changes in glucose homeostasis. As such, before any metabolic effects can be attributed directly to infused PGE2, any metabolic effects can be attributed directly to infused PGE2, the role of concomitant catecholamine release must be considered.

摘要

先前的研究表明,输注前列腺素E2(PGE2)可抑制急性胰岛素释放并导致葡萄糖不耐受。本研究旨在评估PGE2对以下方面的影响:1)胰腺β细胞对葡萄糖的敏感性;2)葡萄糖耐量;3)组织对胰岛素的敏感性;4)葡萄糖生成和清除;5)血浆儿茶酚胺、胰高血糖素和游离脂肪酸(FFA)水平。在开始输注PGE2(10微克/分钟)前和开始后30分钟,使用高血糖钳夹技术(血浆葡萄糖比基础值高125毫克/分升,持续2小时)对6名健康成年受试者进行了研究。在输注PGE2期间测量血浆肾上腺素、去甲肾上腺素和FFA。在额外的实验中,在输注PGE2期间通过同位素([3-3H]葡萄糖)测量葡萄糖生成和利用。PGE2输注使急性胰岛素释放减少,但不显著(输注前0-10分钟,172±36;输注后,148±45微单位/毫升·10分钟)。晚期胰岛素释放(20-120分钟)未改变。葡萄糖代谢量从9±1.1显著下降至7.2±1毫克/千克·分钟。在输注PGE2的最初30分钟内,血浆FFA增加了26±6%(P<0.025)。血浆肾上腺素和去甲肾上腺素分别从40±6上升至104±24皮克/毫升(P<0.05)和从204±17上升至440±30皮克/毫升(P<0.01)。PGE2使葡萄糖输出迅速增加30%,到60分钟时降至基础水平。葡萄糖清除率在45分钟时短暂下降23%。我们得出结论,在输注PGE2期间观察到的对葡萄糖稳态的影响是在肾上腺素能活性增强的情况下发生的。这些代谢反应与肾上腺素能诱导的葡萄糖稳态变化非常相似。因此,在任何代谢效应可直接归因于输注的PGE2之前,必须考虑伴随的儿茶酚胺释放的作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验